SASE OpsLab Partners with Netskope to Revolutionize SASE Deployment at Scale for Frictionless Customer Experience

SASE OpsLab Partners with Netskope to Revolutionize SASE Deployment at Scale for Frictionless Customer Experience Integration uses prepackaged automation to make large-scale SASE rollouts faster, easier, and inherently more secure through error-free tunnel orchestration GlobeNewswire November 12, 2025 DUBLIN, Nov. 12, 2025 (GLOBE NEWSWIRE) — UBiqube, the leader in multi-domain IT infrastructure orchestration and automation, […]

Evaxion announce 2026 financial calendar

Evaxion announce 2026 financial calendar GlobeNewswire November 12, 2025 COPENHAGEN, Denmark, November 12, 2025 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines, announces its financial calendar for 2026 as summarized below: March 5, 2026: Business update and full year 2025 financial results April 16, 2026: Annual General

Interact’s Enterprise Employee Experience Platform Adds Agentic AI to Drive Employee Listening at Scale

Interact's Enterprise Employee Experience Platform Adds Agentic AI to Drive Employee Listening at Scale New features detect sentiment shifts, surface hidden recognition, and deliver answers with agentic AI for managers, HR, and internal communications teams. GlobeNewswire November 12, 2025 MANCHESTER, United Kingdom and NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Interact, the provider of

Cassava Reports Q3 2025 Financials Results and Provides Business Update

Cassava Reports Q3 2025 Financials Results and Provides Business Update GlobeNewswire November 12, 2025 Simufilam advancing towards a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsy Further fortified our strategic capabilities with the appointment of Dawn C. Bir to the Board of Directors $106.1 million in cash and

NewLake Capital Partners CEO Anthony Coniglio to Speak at IgniteIt Cannabis Capital and Policy Summit 2025 on November 17

NewLake Capital Partners CEO Anthony Coniglio to Speak at IgniteIt Cannabis Capital and Policy Summit 2025 on November 17 The discussion will explore how progress on federal rescheduling and banking reform could influence access to capital, accelerate M&A activity, and redefine growth strategies across the cannabis industry GlobeNewswire November 12, 2025 NEW CANAAN, Conn., Nov.

Titan Aviation Leasing Completes Sale of Two Boeing 737-800SF Aircraft to ST Engineering

Titan Aviation Leasing Completes Sale of Two Boeing 737-800SF Aircraft to ST Engineering GlobeNewswire November 12, 2025 DUBLIN, Nov. 12, 2025 (GLOBE NEWSWIRE) — Titan Aviation Leasing (“Titan”), the joint venture between Titan Aviation Holdings, Inc. (a subsidiary of Atlas Air Worldwide) and Bain Capital, today announced the sale of two Boeing 737-800SF aircraft to

Commercial Metals Company Announces Proposed Private Offering of $2,000 Million Senior Notes

Commercial Metals Company (NYSE: CMC) (“CMC” or the “Company”) announced today that it intends to offer to sell, subject to market and other conditions, $2,000 million in aggregate principal amount of new senior unsecured notes (the “Notes”) in an offering (the “Offering”) exempt from the registration requirements of the Securities Act of 1933, as amended

Canadian Investment Regulatory Organization Trade Resumption – GGD

Trading resumes in: Company: GoGold Resources Inc. TSX Symbol: GGD All Issues: Yes Resumption (ET): 08:00 CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

(NASDAQ:ELDN), IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced the pricing of its underwritten public offering of (i) 15,152,485 shares of its common stock at a public offering price of $1.65 per share and (ii) in lieu of common stock to certain investors, pre-funded warrants to purchase

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire November 12, 2025 IRVINE, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced the pricing of its underwritten public offering of (i) 15,152,485 shares of its common stock at a public offering

Scroll to Top